Horizon Technology F (HRZN) 12.03 $HRZN Horizon

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Horizon Technology F (HRZN) 12.03 $HRZN

Horizon Technology Finance Announces First Quarter 2016 Financial Results
GlobeNewswire - Tue May 03, 3:06PM CDT
Net Investment Income Covers Distributions for Third Consecutive Quarter
HRZN: 12.03 (+0.02)

Horizon Technology Finance Adds $25 Million to Revolving Credit Facility
GlobeNewswire - Wed Apr 27, 3:11PM CDT
Horizon Technology Finance Corporation (NASDAQ:HRZN) (the "Company" or "Horizon", a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services and cleantech industries, today announced that its wholly owned subsidiary, Horizon Credit II LLC, has increased the size of its syndicated revolving credit facility ("Credit Facility" led by KeyBank National Association ("Key".
HRZN: 12.03 (+0.02)

Horizon Technology Finance to Announce First Quarter 2016 Financial Results
GlobeNewswire - Tue Apr 19, 3:15PM CDT
Horizon Technology Finance Corporation (NASDAQ:HRZN) (the "Company" or "Horizon", a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today that it plans to release financial results for the first quarter ended March 31, 2016 on Tuesday, May 3, 2016, after the close of market trading.
HRZN: 12.03 (+0.02)

Horizon Technology Finance Provides Investment Portfolio Update for First Quarter 2016
GlobeNewswire - Thu Apr 14, 3:15PM CDT
Horizon Technology Finance Corporation (NASDAQ:HRZN) (the "Company" or "Horizon", a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, today provided a portfolio update for the first quarter of 2016.
HRZN: 12.03 (+0.02)

Horizon Technology Finance posts 4Q profit
Automated Insights - Tue Mar 08, 4:03PM CST
FARMINGTON, Conn. (AP) _ Horizon Technology Finance Corp. (HRZN) on Tuesday reported fourth-quarter earnings of $2.7 million.
HRZN: 12.03 (+0.02)

Horizon Technology Finance Announces Monthly Distributions for April, May and June 2016 Totaling $0.345 Per Share
GlobeNewswire - Tue Mar 08, 3:06PM CST
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon", a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today that its board of directors declared monthly cash distributions of $0.115 per share payable in each of April, May and June 2016. These monthly distributions, payable as set forth in the table below, total $0.345 per share. Including the monthly distributions declared in the first quarter of 2016, Horizon has declared $8.03 per share in cumulative distributions since its October 2010 initial public offering.
HRZN: 12.03 (+0.02)

Horizon Technology Finance Announces Fourth Quarter and Full Year 2015 Financial Results
GlobeNewswire - Tue Mar 08, 3:05PM CST
Generated 22% Portfolio Growth in 2015
HRZN: 12.03 (+0.02)

Horizon Technology Finance Announces New Managing Director
GlobeNewswire - Wed Jan 27, 3:15PM CST
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon", a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services and cleantech industries, today announced that its Advisor, Horizon Technology Finance Management LLC, has named Gregory F. Peter as Managing Director - Business Development.
HRZN: 12.03 (+0.02)

BUYINS.NET: HRZN, VT, CRBQ, TQQQ, BITA Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Jan 15, 6:31AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Horizon Technology Finance Corp (NASDAQ:HRZN), Viterra Inc (NYSE:VT), Thomson Reuters/Jefferies CRB Global Commodity Equity Index (NYSE:CRBQ), ProShares Trust UltraPro QQQ ETF (NASDAQ:TQQQ), Bitauto Holdings Ltd (NYSE:BITA) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
VT: 58.32 (-0.10), CRBQ: 30.24 (-1.57), TQQQ: 96.53 (-0.63), BITA: 25.83 (-0.56), HRZN: 12.03 (+0.02)

Horizon Technology Finance Provides Investment Portfolio Update
GlobeNewswire - Wed Jan 13, 3:15PM CST
Achieves Over 20% Portfolio Growth With 2015 Loan Originations Exceeding $123 Million
XCOM: 0.85 (-0.10), HRZN: 12.03 (+0.02)

Horizon Technology Finance Leads $15 Million Venture Loan for NOMi
GlobeNewswire - Thu Jan 07, 3:05PM CST
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon", a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, today announced it has led a $15 million venture loan for NOMi Corporation ("NOMi".
HRZN: 12.03 (+0.02)

American Capital (ACAS) Up 3.6% on Buyback Announcement
Zacks Equity Research - Zacks Investment Research - Tue Jan 05, 2:15PM CST
American Capital's (ACAS) shares began to rise after the company announced the repurchase of 20.7 million of its common stock for $298.4 million in the fourth quarter of 2015
ACAS: 15.95 (-0.01), GAIN: 7.10 (-0.02), HRZN: 12.03 (+0.02), GSBD: 20.00 (+0.04)

Will Hercules' Active Capital Management Boost Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Dec 22, 9:40AM CST
Hercules (HTGC) is now taking efforts to position it better through active liquidity and balance sheet management in order to capitalize on the changed interest rate environment.
HTGC: 12.14 (unch), BKCC: 7.66 (+0.01), GARS: 9.85 (-0.09), HRZN: 12.03 (+0.02)

Horizon Technology Finance Leads $12 Million Venture Loan Facility for Digital Signal Corporation
GlobeNewswire - Tue Dec 22, 7:30AM CST
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon", a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, today announced it has led a $12 million venture loan facility for Digital Signal Corporation ("DSC".
HRZN: 12.03 (+0.02)

SBIA Makes Case for Small Business Investment at SEC
BusinessWire - Wed Dec 02, 2:03PM CST
The Small Business Investor Alliance (SBIA), the leading association of lower middle market private equity funds and investors, commends the House Financial Services Committee for reviewing legislation that provides an independent voice for small businesses and small business investors at the Securities and Exchange Commission. Arguing the case for SBIA was Christopher M. Mathieu, Chief Financial Officer and co-Founder of Horizon Technology Finance Corporation (NASDAQ:HRZN), a specialty finance company that invests in development and growth stage companies in the technology and life sciences industries.
HRZN: 12.03 (+0.02)

Horizon Technology Finance to Present at the Wells Fargo Middle Market Forum
GlobeNewswire - Wed Nov 11, 7:30AM CST
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon", a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services and cleantech industries, announced today that Christopher M. Mathieu, Chief Financial Officer, is scheduled to present at the Wells Fargo Middle Market Forum at The Plaza Hotel in New York, NY on Tuesday, November 17, 2015 at 12:00 p.m. Eastern time. One-on-one meetings with Horizon may be arranged through Wells Fargo Securities.
WFC: 46.97 (-0.26), HRZN: 12.03 (+0.02)

Hercules Hires Life Sciences Veteran Kristen Kosofsky as Senior Managing Director
BusinessWire - Wed Nov 11, 5:00AM CST
Hercules Technology Growth Capital, Inc. (NYSE:HTGC) ("Hercules", the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced the appointment of Kristen Kosofsky as Senior Managing Director in the Life Sciences Group in Hercules' Boston office.
HTGC: 12.14 (unch), HRZN: 12.03 (+0.02)

Horizon Technology Finance Announces Monthly Distributions for January, February and March 2016 Totaling $0.345 Per Share
GlobeNewswire - Tue Nov 03, 3:06PM CST
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon", a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services and cleantech industries, announced today that its board of directors declared monthly cash distributions of $0.115 per share payable in each of January, February and March 2016. These monthly distributions, payable as set forth in the table below, total $0.345 per share. Including the monthly distributions declared in the fourth quarter of 2015, Horizon has declared $7.685 per share in cumulative distributions since its October 2010 initial public offering.
HRZN: 12.03 (+0.02)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

HeartCore's Journey: From Nasdaq Challenges to Growth Potential

Updated Category News Views 35

HeartCore's Nasdaq Delisting Challenge HeartCore Enterprises, Inc. (NASDAQ:HTCR), a provider of enterprise software and consulting services, is currently facing a significant challenge related to its listing on the Nasdaq Capital Market. The company has received notice of non-compliance with the minimum bid price requirement, which mandates that its stock price must be at...

Continue Reading
Mitchell Capital Expands Portfolio with Optelos Acquisition

Updated Category News Views 236

Mitchell Capital's New Acquisition of Optelos Mitchell Capital, a prominent private equity firm, recently announced a significant acquisition that marks a pivotal moment for their long-term investment strategy. They have secured a controlling interest in Optelos, a distinguished provider of digital twin platforms that are tailored for enhancing critical infrastructure...

Continue Reading
Tampa Bay Lightning and Scripps Sports Forge Exciting Partnership

Updated Category News Views 247

Partnership Announcement Between Tampa Bay Lightning and Scripps Sports The Tampa Bay Lightning have officially entered into an exciting multi-year partnership with Scripps Sports. This collaboration signifies a new chapter for the Tampa Bay Lightning, expanding their reach in broadcasting and enhancing viewer engagement with National Hockey League (NHL) games. Through...

Continue Reading
Kazia Therapeutics Sets Meeting with FDA on Glioblastoma Treatment

Updated Category News Views 61

Kazia Therapeutics Prepares for FDA Meeting on Paxalisib Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is set to meet with the U.S. Food and Drug Administration (FDA) to explore potential pathways for the registration of its innovative drug, Paxalisib, aimed at treating newly diagnosed glioblastoma multiforme (GBM). This crucial...

Continue Reading
Important Notice for Flux Power Investors on Lead Plaintiff Claims

Updated Category News Views 100

Overview of Flux Power Investor Claims Investors with concerns regarding their investments in Flux Power Holdings, Inc. (NASDAQ: FLUX) have much to consider as recent developments unfold. The national securities law firm, Faruqi & Faruqi, LLP, is actively investigating claims that could impact investor interests and is eager to assist those affected. Critical Investment...

Continue Reading